Springer Seminars in Immunopathology

, Volume 3, Issue 4, pp 421–438 | Cite as

The immunopathology of acute type B hepatitis

  • Leonardo Bianchi


Hepatitis Internal Medicine Acute Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alberti A, Diana S, Sculard GH, Eddleston ALWF, Williams R (1978) Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J II: 1056Google Scholar
  2. 2.
    Alberti A, Realdi G, Bortolotti F, Eddleston ALWF, Wiliams R (1980) Dane particle-precipitating antibodies in hepatitis B virus infection. In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and liver. MTP Press, Lancaster, p 59Google Scholar
  3. 3.
    Alberti A, Realdi G, Bortolotti F, Rigoli AM (1977) T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection. Gut 18: 1004Google Scholar
  4. 4.
    Alberti A, Realdi G, Tremolada F, Spina GP, (1976) Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol 25: 396Google Scholar
  5. 5.
    Almeida JD, Rubenstein D, Stott EJ (1971) New antigen-antibody system in Australia-antigenpositive hepatitis. Lancet II: 1225Google Scholar
  6. 6.
    Almeida JD, Waterson AP (1969) Immune complexes in hepatitis. Lancet II: 983Google Scholar
  7. 7.
    Arnold W, Meyer zum Bueschenfelde KH, Hess G, Knolle J (1975) The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBsAg) and IgG for the classification of inflammatory liver diseases. Klin Wochenschr 53: 1069Google Scholar
  8. 8.
    ArnoldW, Nielsen JO, Hardt F, Meyer zum Bueschenfelde KH (1977) Localization of e-antigen in nuclei of hepatocytes in HBsAg-positive liver disease. Gut 19: 994Google Scholar
  9. 9.
    Barker LF, Chisari FV, McGrath PP, Dalgard DW, Kirschenstein RL, Almeida JD, Edgington TS, Sharp DG, Peterson, MR (1973) Transmission of type B viral hepatitis to chimpanzees. J. Infect Dis 127: 648Google Scholar
  10. 10.
    Bernstein IM, Webster KH, Williams RC Jr, Strickland RG (1974) Reduction of circulating T lymphocytes in alcoholic liver disease. Lancet II: 488Google Scholar
  11. 11.
    Bianchi L, De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Wepler W (1977) Acute and chronic hepatitis revisited. Lancet II: 914Google Scholar
  12. 12.
    Bianchi L, Gudat F (1976) Sanded nuclei in hepatitis B. Lab Invest 35: 1Google Scholar
  13. 13.
    Bianchi L, Gudat F (1979) Immunopathology of hepatitis B. In: Popper H, Schaffner F (eds) Progress in liver diseases. Vol. VI, Grune and Stratton, New York, p 371Google Scholar
  14. 14.
    Bianchi L, Zimmerli-Ning M, Gudat F (1979) Viral hepatitis. In: Mac Sween RNM, Anthony PP, Scheuer PJ (eds) Pathology of the liver. Churchill-Livingstone, Edinburgh, p 164Google Scholar
  15. 15.
    Bradley DW, Maynard JE, Berquist KR, Krushak DH (1974) Hepatitis B and serum DNA polymerase activities in chimpanzees. Nature 251: 356Google Scholar
  16. 16.
    Brattig N, Berg PA (1976) Serum inhibitory factors (SIF) inpatients with acute and chronic hepatitis and their clinical significance. Clin Exp Immunol 25: 40Google Scholar
  17. 17.
    Canese MG, Rizzetto M, Arico S, Crivelli O, Zanetti, AR, Macchiorlatti E, Ponzetto A, Leone L, Mello F, Verme G (1979) An ultrastructural and immunohistochemical study on the S antigen associated with the hepatitis B virus. J Pathol 128: 169Google Scholar
  18. 18.
    Chisari FV, Edgington TS (1975) Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med. 142: 1092Google Scholar
  19. 19.
    Chisari FV, Routenberg JA, Anderson DS, Edgington TS (1978) Cellular immune reactivity in HBV-induced liver disease. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis Franklin Institute Press, Philadelphia, p 245Google Scholar
  20. 20.
    Chisari FV, Routenberg JA, Edgington TS (1976) Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infection. J Clin Invest 57: 1227Google Scholar
  21. 21.
    Chisari FV, Routenberg JA, Fiala M, Edgington TS (1977) Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. J Clin. Invest 59: 134Google Scholar
  22. 22.
    Cochrane AMG, Moussouros A, Smith A, Thomson AJ, Eddleston ALWF, Williams R (1976) Autoimmune reaction to liver specific membrane antigen during acute viral hepatitis. Gut 17: 714Google Scholar
  23. 23.
    Cochrane AMG, Moussouros A, Thomson AJ, Eddleston, ALWF, Williams R (1976) Antibodydependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet I: 441Google Scholar
  24. 24.
    Curtiss LK, Edgington TS (1976) Regulatory serum lipoproteins: Regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol 116: 1452Google Scholar
  25. 25.
    Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australiaantigen associated hepatitis. Lancet /I, 695Google Scholar
  26. 26.
    De Cree J, Verhaegen H, De Cock W, Brugmans J (1974) The effect of levamisole on the immunologic response of HBsAg positive patients. Digestion 10: 306Google Scholar
  27. 27.
    Deinhardt F (1976) Epidemiology and mode of transmission of viral hepatitis A and B. Am J Clin Pathol 65: 890 (Suppl)Google Scholar
  28. 28.
    Dienstag JL, Isselbacher KJ, (1978) Liver-specific protein: More questions than answers. N Engl. J Med 299: 40Google Scholar
  29. 29.
    Dienstag JL, Popper H. Purcell RH (1976) The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Pathol 83: 131Google Scholar
  30. 30.
    Dreesman GR, Hollinger FB, Melnick JL (1975) Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBsAg). Am J. Med Sci 270: 123Google Scholar
  31. 31.
    Dudley FJ, Giustino V, Sherlock S (1972) Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J IV: 754Google Scholar
  32. 32.
    Eddleston ALWF (1976) Aetiological factors in immune-mediated liver disease. In: Ferguson A, Mac Sween RNM (eds) Immunological aspects of the liver and gastrointestinal tract. MTP Press, Lancaster p 291Google Scholar
  33. 33.
    Eddleston ALWF, Williams R (1978) HLA and liver disease. Br Med Bull 34: 295Google Scholar
  34. 34.
    Edgington TS, Chisari FV (1975) Immunological aspects of hepatitis B virus infection. Am J Med Sci 270: 213Google Scholar
  35. 35.
    Edgington TS, Chisari FV, (1979) Immune responses to hepatitis B virus coded and induced antigens in chronic active hepatitis. In: Eddleston ALWF, Weber JCP, Williams R (eds) Immune reactions in liver disease. Pitman Medical Publ, Kent, p 44Google Scholar
  36. 36.
    El Sheikh N, Osman CG, Cullens H, Eddleston ALWF, Williams R (1978) T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease. Clin Exp Immunol 31: 150Google Scholar
  37. 37.
    Endo Y, Gudat F, Bianchi L, Mihatsch M, Gasser M, Stalder GA, Schmid M (1978) Anti-HBc im Rahmen der Hepatitis-B-Virusinfektion: Korrelationen zu Entzündungsform und Virusexpression. Schweiz Med Wochenschr 108: 363Google Scholar
  38. 38.
    Erard P (1974) Technical study of the leukocyte migration inhibition test in agarose. Clin Exp Immunol 18: 439Google Scholar
  39. 39.
    Frei PC (1977) Mécanismes immunitaires dans l'hépatite B. Aspects nouveaux et conséquences pratiques. Schweiz Med. Wochenschr 107: 510Google Scholar
  40. 40.
    Frei PC, Erard P, Zinkernagel R (1973) Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute hepatitis B. Biomedicine 19: 379Google Scholar
  41. 41.
    Gelfand SG (1974) Case report: Agammaglobulinemia associated with Australia-antigen-positive chronic active hepatitis. Postgrad Med J 55: 263Google Scholar
  42. 42.
    Germ JL, Shih JWK (1978) Structure of HBsAg and HBcAg. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, p 147Google Scholar
  43. 43.
    Good RA, Page AR (1960) Fatal complications of virus hepatitis in two patients with agammaglobulinemia. Am J Med 29: 804Google Scholar
  44. 44.
    Gudat F, Bianchi L (1977) Evidence for phasic sequences in nuclear HBcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B. Gastroenterology 73: 1194Google Scholar
  45. 45.
    Gudat F, Bianchi L (1977) HBsAg: a target antigen on the liver cell? In: Popper H, Bianchi L, Reutter W (eds) Membrane alterations as basis of liver injury. MTP Press, Lancaster, p 171Google Scholar
  46. 46.
    Gudat F, Bianchi L, Stalder GA, Schmid M, (1980) Diagnostic significance of serological markers in chronic hepatitis B. In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and liver. MTP Press, Lancaster, p 255Google Scholar
  47. 47.
    Gudat F, Bianchi L, Sonnabend W, Thiel G, Aenishaenslin W, Stalder GA (1975) Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab. Invest. 32: 1Google Scholar
  48. 48.
    Hadziyannis S, Gerber MA, Vissoulis C, Popper H (1973) Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers. Arch Pathol 96: 327Google Scholar
  49. 49.
    Hadziyannis S, Vissoulis C, Moussouros A, Afroudakis A (1972) Cytoplasmic localisation of Australia antigen in the liver. Lancet 1: 976Google Scholar
  50. 50.
    Hirschman SZ (1975) Integrator enzyme hypothesis for replication of hepatitis-B virus. Lancet II: 436Google Scholar
  51. 51.
    Hoofnagle JH (1980) Hepatitis B surface antigen (HBsAg) and antibody (anti-HBs). In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and Liver. MTP Press, Lancaster, p 27Google Scholar
  52. 52.
    Hoofnagle JH, Gerety RJ, Barker LF (1975) Antibody to hepatitis B core antigen. Am J Med Sci 270: 179Google Scholar
  53. 53.
    Hoofnagle JH, Seeff LB, Buskell-Bales Z, Zimmerman HJ, and the VA Hepatitis Cooperative Study Group (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298: 1379Google Scholar
  54. 54.
    Hopf U, Meyer zum Bueschenfelde KH, Arnold W (1976) Liver-membrane antibody in chronic active hepatitis. N Engl J Med 294: 578Google Scholar
  55. 55.
    Howard CR, Burrell CJ (1976) Structure and nature of hepatitis B antigen. In: Melnick JL (ed) Progress in medical virology. Vol. 22. Karger, Basel, p.36Google Scholar
  56. 56.
    Howard CR, Zuckerman AJ (1974) Characterization of hepatitis B antigen polypeptides. Intervirology 4: 31Google Scholar
  57. 57.
    Hruska JF, Robinson WS (1977) The proteins of hepatitis B Dane particle cores. J Med Virol 1: 119Google Scholar
  58. 58.
    Huang S (1971) Hepatitis-associated antigen hepatitis: An electron microscopic study of virus-like particles in liver cells. Am J. Pathol 64: 483Google Scholar
  59. 59.
    Huang S (1975) Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. Lab Invest 33: 88Google Scholar
  60. 60.
    Huang SN, Millman I, O'Connell A, Aronoff A, Gault H, Blumberg BS (1972) Virus-like particles in Australia-antigen-associated hepatitis: An immunoelectron microscopic study of human liver. Am J Pathol 67: 453Google Scholar
  61. 61.
    Ibrahim AB, Vyas GN, Perkins HA (1975) Immune response to hepatitis B surface antigen. Infect Immun 11: 137Google Scholar
  62. 62.
    Irwin GR jr, Hierholzer WJ jr, Cimis R, Mc Collum RW (1974) Delayed hypersensitivity in hepatitis B: Clinical correlates of in vitro production of migration inhibition factor. J Infect Dis 130: 580Google Scholar
  63. 63.
    Jain S, Thomas HC, Sherlock S (1977) Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease. Clin Exp Immunol 30: 10Google Scholar
  64. 64.
    Kaplan PM, Germ JL, Alter HJ (1974) Hepatitis B-specific DNA polymerase activity during posttransfusion hepatitis. Nature 249: 762Google Scholar
  65. 65.
    Kim CY, Tilles JG (1973) Purification and biophysical characterization of hepatitis B antigen. J Clin Invest 52: 1176Google Scholar
  66. 66.
    Kohler PF, Trembath J, Merrill DA, Singleton Jw, Dubois RS (1974) Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B. Clin Immunol Immunopathol 2: 465Google Scholar
  67. 67.
    Krugman S, Hoofnagle JH, Gerety RJ, Kaplan PM, Gerin, JL (1974) Viral hepatitis, type B. DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med 290: 133Google Scholar
  68. 68.
    Lam KC, Tong MJ, Rakela J (1977) Release of e antigen from a Dane particle-rich preparation of hepatitis B virus. Infect Immun 16: 403Google Scholar
  69. 69.
    Le Bouvier GL, Mc Collum RW, Hierholzer WJ jr, Irwin GR, Krugman S, Giles JP (1972) Subtypes of Australia antigen and hepatitis B virus. J Am Med Assoc 222: 928Google Scholar
  70. 70.
    Lee WM, Reed WD, Osman CG, Vahrman J, Zuckerman AJ, Eddleston ALWF, Williams R (1977) Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut 18: 250Google Scholar
  71. 71.
    Loewenstein WR (1975) Cellular communication by permeable membrane junctions. In: Weissmann G, Claiborne R (eds) Cell membranes. Hospital Practice Publ, New York, p 105Google Scholar
  72. 72.
    Magnius LO, Espmark JA (1972) New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 109: 1017Google Scholar
  73. 73.
    Meyer zum Bueschenfelde KH, Alberti A, Arnold W, Freudenberg J (1975) Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and nonhepatic diseases. Klin Wochenschr 53: 1061Google Scholar
  74. 74.
    Meyer zum Bueschenfelde KH, Hopf K (1974) Studies on the pathogenesis of experimental chronicactive hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins. Br J Exp Pathol 55: 498Google Scholar
  75. 75.
    Meyer zum Bueschenfelde KH, Huetteroth TH, Arnold W, Hopf U (1979) Immunologic liver injury: The role of hepatitis B viral antigens and liver membrane antigens as targets. In: Popper H, Schaffner F (eds) Progress in liver diseases. Vol. VI. Grune and Stratton, New York, p 407Google Scholar
  76. 76.
    Meyer zum Bueschenfelde KH, Koessling EK, Miescher PA (1972) Liver specific antigens: purification and characterization. Clin Exp Immunol 10: 89Google Scholar
  77. 77.
    Meyer zum Bueschenfelde KH, Manns M, Huetteroth TH, Hopf U, Arnold W (1979) LM-Ag and LSP-two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol 37: 205Google Scholar
  78. 78.
    Mihas AA, Bull DM, Davidson CS (1975) Cell-mediated immunity to liver in patients with alcoholic hepatitis. Lancet 1: 951Google Scholar
  79. 79.
    Miller DJ, Dwyer JM, Klatskin G (1977) Identification of lymphocytes in percutaneous liver biopsy cores. Gastroenterology 72: 1199Google Scholar
  80. 80.
    Miller J, Mitchell CG, Eddleston ALWF, Smith MGM, Reed WD, Williams R (1972) Cell mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet II: 296Google Scholar
  81. 81.
    Moodie J, Stannard LM, Kipps A (1974) Dane complexes in hepatitis B antigen. J. Gen. Virol 24: 375Google Scholar
  82. 82.
    Neurath AR, Strick N (1977) Host specificity of a serum marker for hepatitis B: Evidence that “e antigen” has the properties of an immunoglobulin. Proc. Natl. Acad. Sci. USA 74: 1702Google Scholar
  83. 83.
    Neurath AR, Trepo C, Chen M, Prince AM (1976) Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol 30: 277Google Scholar
  84. 84.
    Newberry UM, Shorey JW, Sanford JP, Combes B (1973) Depression of lymphocyte reactivity to phytohemagglutinin by scrum from patients with liver disease. Cell Immunol 6: 87Google Scholar
  85. 85.
    Nowoslawski A, Brzosko WJ, Madalinkski K, Krawczynski K (1970) Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet I: 494Google Scholar
  86. 86.
    Paronetto F (1976) Immune mechanism in liver disease. In: Ferguson A, Mac Sween RNM (eds) Immunological aspects of the liver and gastrointestinal tract MTP Press, Lancaster, p 319Google Scholar
  87. 87.
    Peterson JM, Dienstag JL, Purcell RH (1975) Immune response to hepatitis viruses. In: Notkins AL (ed) Viral immunology and immunopathology. Academic Press, New York, p 213Google Scholar
  88. 88.
    Popper H (1975) Clinical pathological correlation in viral hepatitis: The effect of the virus on the liver. Am J Pathol 81: 609Google Scholar
  89. 89.
    Popper H, Dienstag JL, Feinstone SM, Alter HJ, Purcell RL (1980) Lessons from the pathology of viral hepatitis in chimpanzees. In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and liver. MTP Press, Lancaster, p 137Google Scholar
  90. 90.
    Popper H, Dienstag JL, Feinstone SM, Alter HJ, Purcell RH (1980) The pathology of viral hepatitis in chimpanzees. Virchows Arch (Pathol Anat) 387: 91Google Scholar
  91. 91.
    Rakela J, Mosley JW, Aach RD, Gitnick GL, Hollinger FB, Stevens CE, Szmuness W (1980) Viral hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. Ref. American Association for the Study of the Liver, Salt Lake City 1980 (Abstr.)Google Scholar
  92. 92.
    Ray MB, Desmet VJ, Bradburne AF, Desmyter J, Fevery J, De Groote J (1976) Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology 71: 462Google Scholar
  93. 93.
    Ray MB, Desmet VJ, Fevery J, De Groote J, Bradburne AF, Desmyter J (1976) Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol 29: 94Google Scholar
  94. 94.
    Reed WD, Eddleston ALWF, Cullens H, Williams R, Zuckerman AJ, Peters DK, Gwyn-Williams DG, Maycock Wd'A (1973) Infusion of hepatitis B antibody in antigen-positive active chronic hepatitis. Lancet II: 1347Google Scholar
  95. 95.
    Reed, WD, Mitchell CG, Eddleston ALWF, Lee WM, Williams R, Zuckerman AJ (1974) Exposure and immunity to hepatitis-B virus in a liver unit. Lancet 1: 581Google Scholar
  96. 96.
    Rizzetto M (1980) Round table discussion on non-A, non-B hepatitis. In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and liver. MTP Press, Lancaster, p 119Google Scholar
  97. 97.
    Rizzetto M, Canese MG, Arico S, Crivelli O, Bonino F, Trepo C, Verme G (1977) Immunofluorescence detection of a new antigen-antibody system (δ/anti-δ) associated to the hepatitis B virus in the liver and in serum of HBsAg carriers. Gut 18: 997Google Scholar
  98. 98.
    Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH (1980) Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect Dis 141: 590Google Scholar
  99. 99.
    Rizzetto M, Shih JWK, Gocke DJ, Purcell RH, Verme G, Gerin JL (1979) Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet /II: 986Google Scholar
  100. 100.
    Robinson WS, Albin C (1980) The structure of hepatitis B virus. In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and liver MTP Press, Lancaster, p 39Google Scholar
  101. 101.
    Robinson WS, Clayton DA, Greenman RL (1974) DNA of a human hepatitis B virus candidate. J Virol 14: 384Google Scholar
  102. 102.
    Robinson WS, Greenman RL (1974) DNA polymerase in the core of the human hepatitis B virus candidate. J Virol 13: 1231Google Scholar
  103. 103.
    Schumacher K, Maerker-Alter G. Wehmer U (1974) A lymphocyte-inhibiting factor isolated from normal human liver. Nature 251: 655Google Scholar
  104. 104.
    Shih, JWK, Gerin JL (1977) Proteins of hepatitis B surface antigen. J Virol 21: 347Google Scholar
  105. 105.
    Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S (1974) Staining methods of Australia antigen in paraffin sections. Detection of cytoplasmic inclusion bodies. Jpn J Exp Med 44: 25Google Scholar
  106. 106.
    Shillitoe EJ, Rapp F (1979) Virus-induced cell surface antigens and cell mediated immune responses. Springer Semin Immunopathol 2: 237Google Scholar
  107. 107.
    Stein O, Fainaru M, Stein Y (1972) Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers. Lab Invest 26: 262Google Scholar
  108. 108.
    Takahashi K, Akahane Y, Gotanda T, Mishiro T, Imai M, Miyakawa Y, Mayumi M (1979) Demonstration of hepatitis e antigen in the core of Dane particles. J Immunol 122: 275Google Scholar
  109. 109.
    Takahashi K, Miyakawa Y, Gotanda T, Mishiro S, Imai M, Mayumi M (1979) Shift from free “small” hepatitis B e antigen to IgG-bound “large” form in the circulation of human beings and a chimpanzee acutely infe with hepatitis B virus Gastroenterology 77: 1193Google Scholar
  110. 110.
    Takahashi K, Yamashita S, Imai M, Miyakawa Y, Mayumi M (1978) Failure of antibody to e antigen to precipitate Dane particles containing DNA polymerase activity and hepatitis B core antigen. J Gen Virol 38: 431Google Scholar
  111. 111.
    Thestrup-Pedersen K, Ladefoged K, Andersen P (1976) Lymphocyte transformation test with liverspecific protein and phytohaemagglutinin in patients with liver disease. Clin Exp Immunol 24:1Google Scholar
  112. 112.
    Tong MJ, Nies KM, Redeker AG (1977) Rapid progression of chronic active type B hepatitis in a patient with hypogammaglobulinemia. Gastroenterology 73: 1418Google Scholar
  113. 113.
    Tong MJ, Wallace AM, Peters RL, Reynolds TB (1975) Lymphocyte stimulation in hepatitis B infections. N Engl J Med 293: 318Google Scholar
  114. 114.
    Trepo C, Hantz O, Vitvitski L, Chevallier P, Williams A, Lemaire JM, Sepetjian M (1978) Heterogeneity and significance of HBsAg: Characterization of a third specificity (es). In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis. The Franklin Institute Press, Philadelphia, p 203Google Scholar
  115. 115.
    Trepo C, Vitvitski L, Neurath R, Hashimoto N, Schaefer R, Nemoz G, Prince AM (1976) Detection of e antigen by immunofluorescense in cytoplasm of hepatocytes of HBsAg carries. Lancet 1: 486Google Scholar
  116. 116.
    Varma RR, Grainger JM, Scheuer PJ (1970) A case of Dubin-Johnson syndrome complicated by acute hepatitis. Gut 11: 817Google Scholar
  117. 117.
    Vyas GN, Peterson DL, Townsend RM, Damle SR, Magnius LO (1977) Hepatitis B “e” antigen: An apparent association with lactate dehydrogenase isozyme-5. Science 198: 1068Google Scholar
  118. 118.
    Wands JR, Perrotto JL, Alpert E, Isselbacher KJ (1975) Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest 55: 921Google Scholar
  119. 119.
    Wansbrough-Jones M, Scullard G, El Sheikh N, Eddleston ALWF, Williams R (1979) Lymphocyte cytotoxicity to HBsAg-coated target cells. In: Eddleston ALWF, Weber JCP, Williams R (eds) Immune reactions in liver disease. Pitman Med Publ Kent, p 61Google Scholar
  120. 120.
    Ware AJ, Eigenbrodt EH, Shorey J, Combes B (1972) Viral hepatitis complicating the DubinJohnson syndrome. Gastroenterology 63: 331Google Scholar
  121. 121.
    Warnatz H (1974) Immune reactions to hepatitis B antigen in acute and chronic hepatitis. Acta Hepatogastroenterol (Stuttg) 21: 237Google Scholar
  122. 122.
    WHO Expert Committee on Viral Hepatitis (1977) Advances in viral hepatitis. WHO Tech Rep Ser: 602.Google Scholar
  123. 123.
    Williams AL, Hosking CS, Wakerfield E (1976) Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers. Lancet I: 486Google Scholar
  124. 124.
    Yoshizawa H, Itoh Y, Simonetti JP, Takahashi T, Machida A, Miyakawa Y, Mayumi M (1979) Demonstration of hepatitis B e antigen in hepatitis core particles obtained from the nucleus of hepatocytes infected with hepatitis B virus. J Gen Virol 42: 513Google Scholar
  125. 125.
    Zinkernagel RM, Althage (1977) Antiviral protection by virus immunocytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 145: 644Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Leonardo Bianchi
    • 1
  1. 1.Department of PathologyUniversity of BaselBaselSwitzerland

Personalised recommendations